Cargando…

Current Status and Physicians’ Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists

BACKGROUND: Data on the status of long-term follow-up (LTFU) care for childhood cancer survivors (CCSs) in Korea is lacking. This study was conducted to evaluate the current status of LTFU care for CCSs and relevant physicians’ perspectives. METHODS: A nationwide online survey of pediatric hematolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ji Won, Yeo, Yohwan, Ju, Hee Young, Cho, Hee Won, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe, Jeong, Su-Min, Shin, Dong Wook, Baek, Hee Jo, Kook, Hoon, Chung, Nack-Gyun, Cho, Bin, Kim, Young Ae, Park, Hyeon Jin, Song, Yun-Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366409/ https://www.ncbi.nlm.nih.gov/pubmed/37489718 http://dx.doi.org/10.3346/jkms.2023.38.e230

Ejemplares similares

Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey
por: Shin, Dong Wook, et al.
Publicado: (2015)

Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
por: Cho, Hee Won, et al.
Publicado: (2018)

Therapy-related myeloid neoplasms in children and adolescents
por: Cho, Hee Won, et al.
Publicado: (2016)

Conditioning with 10 Gy Total Body Irradiation, Cyclophosphamide, and Fludarabine without ATG Is Associated with Improved Outcome of Cord Blood Transplantation in Children with Acute Leukemia
por: Cho, Hee Won, et al.
Publicado: (2021)

Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma
por: Bae, Joon Seol, et al.
Publicado: (2022)

Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population
por: Lim, Hana, et al.
Publicado: (2020)

Applying spatial epidemiology to hematological disease using R: a guide for hematologists and oncologists
por: Kohno, Kei, et al.
Publicado: (2014)

Transfusion Practices in the Management of Sickle Cell Disease: A Survey of Florida Hematologists/Oncologists
por: Dunbar, Levette N., et al.
Publicado: (2012)

Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists
por: Beck, Jill C, et al.
Publicado: (2017)

Second wave of COVID-19 – Not a matter of great concern for pediatric hematologist/oncologist
por: Bansal, Minakshi, et al.
Publicado: (2022)

Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support
por: Lee, Alfred Ian, et al.
Publicado: (2022)

Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma
por: Seo, Eunseop, et al.
Publicado: (2019)

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
por: Lee, Ji Won, et al.
Publicado: (2022)

The Spectrum of Epstein-Barr Virus-Associated Lymphoproliferative Disease in Korea: Incidence of Disease Entities by Age Groups
por: Cho, Eun-Yoon, et al.
Publicado: (2008)

Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors
por: Lee, Ji Won, et al.
Publicado: (2019)

Erratum: Correction of Title: Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
por: Choi, Young Bae, et al.
Publicado: (2019)

Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
por: Choi, Young Bae, et al.
Publicado: (2019)

Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma
por: Seo, Eun Seop, et al.
Publicado: (2020)

Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification
por: Cho, Hee Won, et al.
Publicado: (2022)

A survey of pediatric hematologists/oncologists’ perspectives on single patient Expanded Access and Right to Try
por: Chapman, Carolyn Riley, et al.
Publicado: (2021)

Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
por: Lee, Ji Won, et al.
Publicado: (2017)

Health behaviors of caregivers of childhood cancer survivors: a cross-sectional study
por: Cho, In Young, et al.
Publicado: (2020)

DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes
por: Ju, Hee Young, et al.
Publicado: (2021)

Impact of legislation and public funding on oncofertility: a survey of Canadian, French and Moroccan pediatric hematologists/oncologists
por: Affdal, Aliya Oulaya, et al.
Publicado: (2020)

Idarubicin Plus Behenoyl Cytarabine and 6-thioguanine Compares Favorably with Idarubicin Plus Cytarabine-based Regimen for Children with Previously Untreated Acute Myeloid Leukemia: 10-Year Retrospective, Multicenter Study in Korea
por: Lee, Dae Hyoung, et al.
Publicado: (2010)

Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: A Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group
por: Park, Kyung Mi, et al.
Publicado: (2022)

A Study on Altered Expression of Serine Palmitoyltransferase and Ceramidase in Psoriatic Skin Lesion
por: Hong, Kyung-Kook, et al.
Publicado: (2007)

Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma
por: Lee, Ji Won, et al.
Publicado: (2020)

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma
por: Kim, Chiwoo, et al.
Publicado: (2018)

Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea
por: Ju, Hee Young, et al.
Publicado: (2018)

High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas
por: Choi, Young Bae, et al.
Publicado: (2016)

Efficacy of Tandem High-Dose Chemotherapy and Autologous Stem Cell Rescue in Patients Over 1 Year of Age with Stage 4 Neuroblastoma: The Korean Society of Pediatric Hematology-Oncology Experience Over 6 Years (2000-2005)
por: Sung, Ki Woong, et al.
Publicado: (2010)

Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma
por: Lee, Na Hee, et al.
Publicado: (2016)

Gaucher Disease for Hematologists
por: Özdemir, Gül Nihal, et al.
Publicado: (2022)

Nationwide Statistical Analysis of Lymphoid Malignancies in Korea
por: Lee, Hyewon, et al.
Publicado: (2018)

Responses and adverse effects of carboplatin-based chemotherapy for pediatric intracranial germ cell tumors
por: Ji, Suntae, et al.
Publicado: (2011)

Evaluation of How Integrative Oncology Services Are Valued between Hematology/Oncology Patients and Hematologists/Oncologists at a Tertiary Care Center
por: Hansra, D. M., et al.
Publicado: (2018)

Optimal Time to Start Peripheral Blood Stem Cell Collection in Children with High-Risk Solid Tumors
por: Sung, Ki Woong, et al.
Publicado: (2014)

MBCL-28. LONG-TERM FOLLOW-UP RESULTS OF REDUCED DOSE CRANIOSPINAL RADIOTHERAPY AND TANDEM HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK MEDULLOBLASTOMA
por: Lee, Ji Won, et al.
Publicado: (2020)

Korea hypertension fact sheet 2020: analysis of nationwide population-based data
por: Kim, Hyeon Chang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r9n3qq4ep3ra6dos45l50oj6td